The present invention is directed to compounds, their synthesis, and their use as antagonists, inverse agonists, modulators and or inhibitors of the Retinoic acid-related orphan nuclear receptor &gamma；t (ROR&gamma；t)/ROR&gamma；. The compounds of the present invention are useful for modulating ROR&gamma；t)/ROR&gamma； activity and for treating diseases or conditions mediated by ROR&gamma；t)/ROR&gamma； such as for example, disease states associated with immunopathology of human autoimmune diseases such as Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), Inflammatory Colitis, Psoriasis, COPD, Pain, Obesity, Diabetes, Dyslipidemia, Osteoporosis, Asthma, Neurodegenerative diseases and Cancer.
